Latest news
Search news stories
Enter a keyword to search news.
ENZAMET shows promise as prostate cancer treatment
The results from the clinical trial of ENZAMET, co-chaired by Professor Christopher Sweeney, Director of the South Australian immunoGENomics Cancer Institute (SAiGENCI) that operates within the University of Adelaide, have been published today in The Lancet Oncology .
[Read more about ENZAMET shows promise as prostate cancer treatment ]
Top talent to boost cancer research
The search for a tailored treatment for cancerous tumours has been bolstered with the appointment of an internationally recognised expert to the South Australian immunoGENomics Cancer Institute (SAiGENCI).
David Beale PhD Supplementary Scholarship in Prostate Cancer Research
The David Beale PhD Supplementary Scholarship in Prostate Cancer Research was established in 2023 from a generous donation to the University from David Beale to support outstanding emerging researchers in better understanding the causes and exploring potential treatments and cures for prostate cancer.
[Read more about David Beale PhD Supplementary Scholarship in Prostate Cancer Research]
Dr Shanice Mah awarded Cancer Council Beat Cancer Project Fellowship
Dr Shanice Mah, from SAiGENCI's Hormone Dependent Cancers program, has been awarded an Early Career Research Fellowship through the Cancer Council Beat Cancer Project.
[Read more about Dr Shanice Mah awarded Cancer Council Beat Cancer Project Fellowship]
